UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002095 |
|---|---|
| Receipt number | R000002558 |
| Scientific Title | Phase II study of cisplatin, docetaxel, and irinotecan, followed by gefitinib, gemcitabine and vinorelbine for patients with non-small-cell lung cancer harboring active EGFR gene mutations (OLCSG0704) |
| Date of disclosure of the study information | 2009/08/01 |
| Last modified on | 2015/12/20 10:52:18 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/06/19 17:29:43 | ||
| 2 | Update | 2011/12/19 14:03:43 | Name of person sending information Organization Organization Division name Division name Address Address TEL Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2013/12/19 11:47:44 | Email |
|
| 4 | Update | 2015/01/08 18:14:37 | UMIN ID1 |
|
| 5 | Update | 2015/12/20 10:52:18 | Recruitment status Results |
